Kraus & Lederer patent opposition analysis

The comprehensive analysis of Kraus & Lederer opposition landscape, with a particular emphasis on intellectual property (IP) dynamics.

Stay updated with the latest patent oppositions filed by Kraus & Lederer

Patent NumberTitleApplicantOpposition DateOpposition Company
Method For Isolating Proteins And Saccharides From YeastYEASTUPJan 15, 2026KRAUS & LEDERER PARTGMBB
Manufacture Of A Crystalline Pharmaceutical ProductORIONJan 8, 2026KRAUS & LEDERER PARTGMBB
Treatment Of HypoparathyroidismENTERA BIODec 29, 2025KRAUS & LEDERER PARTGMBB
Crystal Form Of Ozanimod, Crystal Form Of Hydrochloride Thereof, And Preparation Method ThereforCRYSTAL PHARMACEUTICAL SUZHOUDec 23, 2025SANDOZ
Propylene-Ethylene Random Copolymers With Low Xs/Et Ratio And High MfrW R GRACE & CONNNov 19, 2025KRAUS & LEDERER PARTGMBB
Fenfluramine Compositions And Methods Of Preparing The SameZOGENIXOct 23, 2025SANDOZ
Pharmaceutical Composition, Methods For Treating And Uses ThereofBOEHRINGER INGELHEIMSep 12, 2025TEVA PHARMACEUTICALS
Sodium (2R, 5S, 13Ar) -7, 9-Dioxo-10- ( (2,4,6-Trifluorobenzyl) Carbamoyl) -2, 3, 4, 5, 7, 9, 13, 13A-Octahydro-2, 5-Methanopyrido [1',2' : 4.5] Pyrazino [2, 1-B] Oxazepin-8-OlateGILEAD SCIENCESSep 3, 2025KRAUS & LEDERER PARTGMBB
Preparation Containing Tetracyclic Compound At High DoseCHUGAI SEIYAKU KABUSHIKI KAISHAAug 19, 2025TEVA PHARMACEUTICALS
Nanoemulsion For Oral UseNICOVENTURESAug 5, 2025DSM ASSETS